News

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - imaging, diagnostics industry, including QuidelOrtho (NASDAQ:QDEL) and its peers.

The past six months haven’t been great for Zebra. It just made a new 52-week low of $237, and shareholders have lost 35.4% of their capital. This might have investors contemplating their next move.

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the advertising & marketing services industry, including Taboola (NASDAQ:TBLA) and its peers.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Haemonetics (NYSE:HAE) and the best and worst performers in the medical devices & supplies - specialty industry.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how sit-down dining stocks fared in Q4, starting with Cracker Barrel (NASDAQ:CBRL).

Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at finance and HR software stocks, starting with Intuit (NASDAQ:INTU).